Company
United StatesPublic company, NASDAQ: HALOHALOZYME THERAPEUTICS, INC. (NASDAQ: HALO), San Diego, CA – FDA Inspections
Inspection records and compliance data for HALOZYME THERAPEUTICS, INC. in San Diego, California. 1 FDA inspection on record, last inspected June 17, 2009. Publicly traded as NASDAQ: HALO.
Company Profile
This profile covers HALOZYME THERAPEUTICS, INC. based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 17, 2009.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 17, 2009 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 591628 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
HALOZYME THERAPEUTICS, INC.
Stock ticker
HALO
Exchange
NASDAQ
Share price
$123.61
Market cap
$14.0B
Price as of
November 6, 2026
FEI Number
3027956868
Address
12390 El Camino Real, San Diego, California 92130, United States
Country
United States
ID: 83387fde-f29b-4167-a479-4e96ac1239bc